Front Cover: Structure‐Activity Relationships of Benzamides and Isoindolines Designed as SARS‐CoV Protease Inhibitors Effective against SARS‐CoV‐2 (2/2021)
ChemMedChem2021Vol. 16(2), pp. 301–301
Armin Welker, Christian Kersten, Christin Müller, Ramakanth Madhugiri, Collin Zimmer, Patrick Müller, Robert A. Zimmermann, Stefan Hammerschmidt, Hannah Maus, John Ziebuhr, Christoph Sotriffer, Tanja Schirmeister
Abstract
The Front Cover presents an experimental weapon changing the outcome of a battle in the respiratory system. The picture shows severe acute respiratory syndrome corona virus (SARS-CoV) particles and the virus′ own papain-like protease (PLpro, PDB-ID 3E9S) through the window of a cockpit. The essential protease is targeted and "bombarded" with the novel inhibitors shown on the screens. Hitting the protease leads to the destruction of the viruses. The corresponding article describes inhibitors developed for SARS-CoV PLpro and examines the transferability of their effectiveness to the close homologue of SARS-CoV-2. More information can be found in the Full Paper by Tanja Schirmeister et al.. Cover designed by Hannah and Lea Maus.
Related Papers
- → Cover 1 (Outside Front Cover) and Cover 2 (Inside Front Cover)(2021)
- → Cover 1 (Outside Front Cover) and Cover 2 (Inside Front Cover)(2021)
- → Cover 1 (Outside Front Cover) and Cover 2 (Inside Front Cover)(2019)
- → Cover 1 (Outside Front Cover) and Cover 2 (Inside Front Cover)(2020)
- → Cover 1 (Outside Front Cover) and Cover 2 (Inside Front Cover)(2019)